The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a alike https://sahilpdwm112227.wikinewspaper.com/4297289/retatrutide_vs_tirzepatide_a_comparative_analysis